Pentam 300 (APP Pharmaceuticals, LLC)


Welcome to the PulseAid listing for the Pentam 300 drug offered from APP Pharmaceuticals, LLC. This Antiprotozoal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: APP Pharmaceuticals, LLC
NON-PROPRIETARY NAME: PENTAMIDINE ISETHIONATE
SUBSTANCE NAME: PENTAMIDINE ISETHIONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiprotozoal [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2001-01-16
END MARKETING DATE: 0000-00-00


Pentam 300 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPentam 300 from APP Pharmaceuticals, LLC
LABELER NAME: APP Pharmaceuticals, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 300(mg/3mL)
START MARKETING DATE: 2001-01-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-113_2cd3bffe-b3ad-4a79-b782-6880ee48afb0
PRODUCT NDC: 63323-113
APPLICATION NUMBER: NDA019264

Other PENTAMIDINE ISETHIONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
APP Pharmaceuticals, LLCPentam 300
Fresenius Kabi USA, LLCNebuPent
Seton PharmaceuticalsPentamidine Isethionate